IV AAEP News July 2022
ASSOCIATION Delve into endocrine disease, ethical mentorship during August Round Tables
Help protect your clients’ horses from a common cause of laminitis by getting the low-down on diagnosing and managing endocrine disease during the August 10 episode of the AAEP’s Virtual Wednesday Round Tables.
The Round Tables are offered on the second and fourth Wednesday of every month through October. The sessions are free for members, who simply need to register in advance through AAEP Anywhere at
aaepanywhere.org.
Following is the upcoming schedule of tentative session topics:
July 27: Accounts Receivable
August 10: Fat, Fuzzy, or Foundered? Approach to Diagnosis and Management of Horses with Endocrine Disease
August 24: Ethical Mentorship in Equine Practice: Important Discussions from Day 1 to Retirement
As a reminder, sessions are recorded and made available for viewing on-demand through AAEP Anywhere, the association’s free-to-members online learning platform. On-demand sessions are available 48 hours following the live session and include mentioned resources such as PowerPoint slides, images and more. CE credit is not offered for the Round Tables.
The Virtual Wednesday Round Tables are sponsored by:
AAEP publishes Nocardioform Placentitis Guidelines
Help protect your clients’ broodmares and unborn foals with the AAEP’s new Nocardioform Placentitis (NP) Guidelines. The guidelines present the clinical features, risk factors, treatment, control measures and more for a form of bacterial placentitis that can cause abortion, stillbirth, or delivery of a weak premature or term foal.
NP was first diagnosed in central Kentucky in the mid-1980s, and its occurrence since has varied from sporadic cases to outbreak years in the region. Outside of Kentucky and the United States, NP has been reported primarily as isolated cases and rarely as outbreaks. The suggested window from exposure to clinical signs is generally three to five months. In addition, there is a strong association between weather conditions during mid- to late-pregnancy and increased occurrence of NP, specifically exposure to low rainfall and high tempera- tures during August and September in central Kentucky.
“The insidious nature of NP makes the early diagnosis and onset of treatment rather challenging in clinical practice,” said guidelines co-author Dr. Igor Canisso, associate professor of theriogenology at the University of Illinois College of Veterinary Medicine.
Attempts to create experimental NP infection have been unsuccessful, limiting evidence-based assessment of therapy efficacy. Currently, mares suspected to have NP based on ultrasonographic lesions are usually empirically treated with antibiotics (e.g., sulfa, doxycycline, or gentamicin), anti-inflammatories (flunixin or firocoxib), steroids (altrenogest and/or estrogens) and supporting medications (pentoxifylline and vitamin E).
Dr. Canisso co-authored the Nocardioform Placentitis Guidelines with Dr. Maria Schnobrich, shareholder and theriogenologist at Rood & Riddle Equine Hospital; Dr. Carleigh Fedorka, postdoctoral fellow at the University of Kentucky’s Maxwell H. Gluck Equine Research Center; and Dr. Barry Ball, who recently retired as the Albert G. Clay Endowed Chair and Professor in Equine Reproduction at the Gluck Equine Research Center.
View the Nocardioform Placentitis Guidelines or save them to your mobile device as a PDF file at
aaep.org/ document/nocardioform-placentitis. Besides Nocardio- form Placentitis, AAEP guidelines for 23 additional equine infectious diseases can be found at
aaep.org/ guidelines/infectious-disease-control/using-guidelines. In addition, five foreign animal disease guidelines are available at
aaep.org/infectious-disease-control/ foreign-animal-disease-guidelines.
Dr. Laurie Metcalfe
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88
